首页> 外文期刊>BMC Musculoskeletal Disorders >Study Protocol- Lumbar Epidural Steroid Injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults
【24h】

Study Protocol- Lumbar Epidural Steroid Injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults

机译:研究方案-腰椎硬膜外类固醇激素注射治疗椎管狭窄症(LESS):硬膜外类固醇注射剂治疗老年人腰椎管狭窄症的双盲随机对照试验

获取原文
       

摘要

Background Lumbar spinal stenosis is one of the most common causes of low back pain among older adults and can cause significant disability. Despite its prevalence, treatment of spinal stenosis symptoms remains controversial. Epidural steroid injections are used with increasing frequency as a less invasive, potentially safer, and more cost-effective treatment than surgery. However, there is a lack of data to judge the effectiveness and safety of epidural steroid injections for spinal stenosis. We describe our prospective, double-blind, randomized controlled trial that tests the hypothesis that epidural injections with steroids plus local anesthetic are more effective than epidural injections of local anesthetic alone in improving pain and function among older adults with lumbar spinal stenosis. Methods We will recruit up to 400 patients with lumbar central canal spinal stenosis from at least 9 clinical sites over 2 years. Patients with spinal instability who require surgical fusion, a history of prior lumbar surgery, or prior epidural steroid injection within the past 6 months are excluded. Participants are randomly assigned to receive either ESI with local anesthetic or the control intervention (epidural injections with local anesthetic alone). Subjects receive up to 2 injections prior to the primary endpoint at 6 weeks, at which time they may choose to crossover to the other intervention. Participants complete validated, standardized measures of pain, functional disability, and health-related quality of life at baseline and at 3 weeks, 6 weeks, and 3, 6, and 12 months after randomization. The primary outcomes are Roland-Morris Disability Questionnaire and a numerical rating scale measure of pain intensity at 6 weeks. In order to better understand their safety, we also measure cortisol, HbA1c, fasting blood glucose, weight, and blood pressure at baseline, and at 3 and 6 weeks post-injection. We also obtain data on resource utilization and costs to assess cost-effectiveness of epidural steroid injection. Discussion This study is the first multi-center, double-blind RCT to evaluate the effectiveness of epidural steroid injections in improving pain and function among older adults with lumbar spinal stenosis. The study will also yield data on the safety and cost-effectiveness of this procedure for older adults. Trial Registration Clinicaltrials.gov NCT01238536
机译:背景技术腰椎管狭窄症是老年人下腰痛的最常见原因之一,可导致严重的残疾。尽管它很普遍,但是脊椎狭窄症状的治疗仍存在争议。与外科手术相比,硬膜外注射类固醇激素的频率越来越高,其侵入性更小,潜在的安全性更高,成本效益更高。然而,目前尚缺乏判断硬膜外注射类固醇激素治疗椎管狭窄的有效性和安全性的数据。我们描述了一项前瞻性,双盲,随机对照试验,该试验测试了以下假设:硬膜外注射类固醇加局部麻醉药比单独硬膜外注射硬膜外注射在改善腰椎管狭窄的老年人的疼痛和功能方面更有效。方法我们将在2年内从至少9个临床地点招募多达400名腰椎中央管狭窄的患者。过去6个月内需要手术融合,既往有腰椎手术史或先前有硬膜外类固醇注射史的脊柱不稳患者被排除在外。参与者被随机分配接受局部麻醉的ESI或对照干预(仅硬膜外注射局部麻醉的硬膜外注射)。在第6周时,受试者在主要终点之前最多接受2次注射,此时他们可以选择过渡到其他干预措施。参与者在基线,随机化后3周,6周以及3、6和12个月时完成疼痛,功能障碍和健康相关生活质量的经过验证的标准化度量。主要结果是罗兰·莫里斯(Roland-Morris)残疾问卷和6周时疼痛强度的数字量表。为了更好地了解它们的安全性,我们还在基线以及注射后3周和6周时测量了皮质醇,HbA1c,空腹血糖,体重和血压。我们还获得有关资源利用和成本的数据,以评估硬膜外类固醇注射的成本效益。讨论这项研究是第一个评估硬膜外类固醇激素注射改善老年腰椎管狭窄症患者疼痛和功能的有效性的多中心,双盲RCT。这项研究还将得出有关该方法对老年人的安全性和成本效益的数据。试用注册Clinicaltrials.gov NCT01238536

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号